Article · 2016
Editor
Samir A Farghaly
Cornell University, USA
About
As published by the journal they serve.
Samir A Farghaly is a Physician/Scientist, and faculty member of the Medical College of Cornell University and The New York Presbyterian Hospital /Cornell University Medical Center, New York, NY, USA. He received his M.D Degree from University College London University (1985), and his PhD Degree in molecular biology from London university (1993). He received several clinical and research awards. He has been an invited speaker in several national and international conferences on cancer. He is a member of several national and international societies, organization and foundation of cancer and women health . He is an editor, member of editorial boards and reviewers of several medical journals of Oncology, Gynecology and Gynecological Cancers. He has published 74 articles. He is an editor of a book on ovarian cancer.
Qualifications
MD, PhD
Journals they serve
The seats these journals name them in.
- Cancer Science & TherapyEditor
- Cancer Science & TherapyEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2011
The status of anti-metastatic gene therapy in patients with advanced epithelial ovarian cancer
Article · 2014
Novel Targeted Therapies for Patients with Ovarian Cancer
Article · 2013
siRNA formulated with tumor targeting scFv modified lph nanoparticles as possible therapy for Metastaic epithelial ovarian cancer
Article · 2013
The Role of Oral Contraceptive Pills (OCPs) in Chemoprevention of Epithelial Ovarian Cancer in Women with Mutant BRCA1 and BRCA2 Genes
Article · 2011
The status of anti-metastatic gene therapy in patients with advanced epithelial ovarian cancer
Article · 2017
Combination epigenetic therapy for recurrent platinum resistant-platinum refractory epithelial ovarian cancer
Article · 2016
Mesothelin Expression in Ovarian Cancer and its potential as Targeted Ovarian cancer Immunotherapy
Article · 2016
Mesothelin expression in ovarian cancer and its potential as targeted ovarian cancer immunotherapy
Article · 2013
Epithelial to mesenchymal transition (EMT), as a targeted therapy for multidrug resistance in epithelial ovarian cancer
Article · 2021
Gynecologic Cancer 2017: Combination epigenetic therapy for recurrent platinum resistantplatinum refractory epithelial ovarian-cancerSamir A Farghaly- Cornell University
Article · 2014
Epithelial to mesenchymal transition (EMT), as a targeted therapy for multi drug resistance in epithelial ovarian cancer
Article · 2012
Anti- Metastatic Gene Therapy in Patients with Advanced Epithelial Ovarian Cancer (EOC)
Article · 2012
Protein kinase braf inhibitors as targeted therapy for border line epithelial ovarian tumors
Article · 2012
Cd133 biomarker as a potential cancer stem cells therapy for epithelialovarian cancer (EOC)
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.